2014


24.    Neil Robertson and  Mehmet V. Yigit. The Role of miRNAs in Resistance to Breast Cancer Therapy”, Wiley Interdisciplinary Reviews (WIREs) RNA, in press.





23.    Muhit Rana, Mustafa Balcioglu, and  Mehmet V. YigitLocked nucleic acid-modified antisense miR-10b oligonucleotides form stable duplexes on gold nanoparticles", BioNanoScience, 4(2), 2014, 195-200.







22.    Byunghee YooSubrata K. Ghosh, Mohanraja Kumar, Anna Moore,  Mehmet V. Yigit and Zdravka MedarovaDesign of Nanodrugs for miRNA Targeting in Tumor Cells"Journal of Biomedical Nanotechnology 10(6), 2014, 1114-1122.





21.    Byunghee Yoo, Amol Kavishwar, Subrata K. Ghosh, Mehmet V. Yigit, Anna Moore, and Zdravka Medarova. Detection of miRNA Expression in Intact Cells Using Activatable Sensor Oligonucleotides”, Chem Biol. 2014, in press

                                                                                                          



20.    Muhit Rana, Mustafa Balcioglu, Neil Robertson and  Mehmet V. Yigit. Nano-graphene oxide as a novel platform for monitoring the effect of LNA modification in nucleic acid interactions”, Analyst, 2014, 139 (4), 714 - 720




 



19.    Subrata K. Ghosh, Mehmet V. Yigit, Masashi Uchida, Alana W. Ross, Natalie Barteneva, Anna Moore and Zdravka Medarova. Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma”, Int. J. Cancer, 2014, 134 (7), 1758–1766


 

2013


18.    Mustafa Balcioglu, Muhit Rana and Mehmet V. YigitDoxorubicin loading on graphene oxide, iron oxide and gold nanoparticle hybrid”, Journal of Materials Chemistry B, 2013, 1 (45), 6187 - 6193


                                                                                      



17.     Mehmet V. Yigit, Subrata K. Ghosh, Mohanraja Kumar, Victoria Petkova, Anna Moore and Zdravka Medarova. “Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis” Oncogene, 2013, 32(12), 1530-1538.




 2012


16.    Ping Wang, Mehmet V. Yigit, Chongzhao Ran, Alana Ross, Lingling Wei, Guangping Dai, Zdravka Medarova and Anna Moore. “A Theranostic Small Interfering RNA Nanoprobe Protects Pancreatic Islet Grafts From Adoptively Transferred Immune Rejection” Diabetes, 2012, 61(12), 3247-3254.





15.    Mehmet V. Yigit, and Zdravka Medarova. "Iron Oxide Nanoparticles and Derivatives for Biomedical Imaging and Application in Cancer Diagnosis and siRNA Therapy Nano and Micro Flow Systems for Bioanalysis, Editors: M.W.Collins & C.S.König, Chapter 1, Springer, 2013.



14.    Mehmet V. Yigit, Anna Moore and Zdravka Medarova. “Magnetic nanoparticles for cancer diagnosis and therapy” Pharmaceutical Research, 2012, 29(5), 1180-1188.



13.     Mehmet V. Yigit, Anna Moore and Zdravka Medarova. “In vivo application of gold nanoparticles for biomedical SERS imaging”, Am. J. Nucl. Med. Mol. Imaging, 2012, 2(2), 232-241.



 2011

12.     Mehmet V. Yigit, Leyun Zhu, Marytheresa A. Ifediba, Yong Zhang, Kevin Carr, Anna Moore, and Zdravka Medarova. “Noninvasive MRI-SERS imaging in living mice using an innately bimodal nanomaterial” ACS Nano, 2011, 5(2), 1056–1066.




11.     Ping Wang, Mehmet V. Yigit, Liangli Wei, Guangping Dai, Zdravka Medarova, and Anna Moore. “Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantation” Diabetes, 2011, 60(2), 565-571.



2010


10.     Mohanraja Kumar, Mehmet Yigit, Guangping Dai, Anna Moore and Zdravka Medarova. “Image-guided breast tumor therapy using a siRNA nanodrug” Cancer Research, 2010, 70(19),7553-7561.



9.     Jung Heon Lee, Mehmet V. Yigit, Debapriya Mazumdar and Yi Lu. “Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates” Adv. Drug Deliv. Rev. 2010, 62(6),592-605.



2009 and earlier

8.   Mehmet V. Yigit, Abhijit Mishra, Rong Tong, Jianjung Chen, Gerard C. L. Wong and Yi Lu. “Inorganic mercury detection and controlled release of chelating agents from ion-responsive liposomes” Chem Biol. 2009, 16(9), 937-942.



7.   Mehmet V. Yigit, Debapriya Mazumdar and Yi Lu. “MRI Detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles” Bioconjugate Chem., 2008, 19(2),412-417.



6.   Mehmet V. Yigit, Debapriya Mazumdar, Hee-Kyung Kim, Jung Heon Lee, Boris Odintsov and Yi Lu. “Smart "turn-on" magnetic resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide nanoparticles” ChemBioChem 2007,8(14), 1675-1678.



5.   Jung Heon Lee, Daryl P. Wernette, Mehmet V. Yigit, Juewen Liu, Zidong Wang and Yi Lu. “Site-specific control of distances between gold nanoparticles using phosphorothioate anchors on DNA and a short bifunctional molecular fastener” Angew. Chem. Int. Ed., 2007, 46(47),9006-9010.



4.    Mehmet V. Yigit, Christopher G. F. Cooper, Yu Wang, Brian Moulton and John C. MacDonald. “Reaction of 1,2-bis(2,6-dicarboxypyridin-4-yl)ethyne with Co(II) generates coordination monomers not polymers: Crystal structure of 4-(2,6-dicarboxypyridin-4-yl)ethynylpyridine-2,6- dicarboxylatotriaqua cobalt(II) monohydrate” Journal of Chemical Crystallography 2006, 36(6), 371-379.


3.   Mehmet V. Yigit, Yu Wang, Brian Moulton and John C. MacDonald. “Generation of linear coordination polymers of catena-[diaqua-(m-pyrazine-2,6-dicarboxylato-N,O,O'-m-N')copper(II)] via in situ hydro(solvo)thermal decarboxylation of pyrazine-2,3,5,6-tetracarboxylic acid” Crystal Growth & Design2006, 6(4), 829-832.

2.   Mehmet V. Yigit, Kasim Biyikli, Brian Moulton and John C. MacDonald. “Bis(imidazolium 2,4,6-tricarboxypyridine) metal(II) complexes: Molecular building blocks that generate isomorphous hydrogen-bonded frameworksCrystal Growth & Design 2006, 6(1), 63-69.


1.   John C. MacDonald, Mehmet V. Yigit and Kyle Mychajlonka. “Two concomitant polymorphs of a supramolecular model of the Asp---His---Ser catalytic triad” Crystal Growth & Design 2005, 5(6),2248-2255